Estradiol Completed Phase 3 Trials for Cardiovascular Heart Disease / Myocardial Ischemia / Coronary Heart Disease (CHD) / Heart Diseases / one to five years postmenopausal Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000559Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)